Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)
Document Type
Journal Article
Publication Date
2010
Journal
Diabetes Care
Volume
33
Issue
1
Inclusive Pages
177-183
APA Citation
Kahn, S., Haffner, S., Viberti, G., Herman, W., & Lachin, J. (2010). Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care, 33 (1). Retrieved from https://hsrc.himmelfarb.gwu.edu/sphhs_epibiostats_facpubs/1051
COinS